Lilly To Provide Free Access to Drug Discovery Platform Under New Collaborative Initiative
June 15, 2009
Lilly To Provide Free Access to Drug Discovery Platform Under New Collaborative Initiative
By a GenomeWeb staff reporter
Findings from the initiative "could ultimately form the basis for collaboration or licensing agreements between Lilly and external institutions," the company said.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.